IL2 and neoplasm: Combined administration of AKK and IL-2 has a better tumor suppressive effect than single administration, altering the TME, except affecting immune cells, and inducing the production of pro-inflammatory cytokines, significantly increasing IFN-γ and IL-2 levels in tumor tissues (Table 1) (Figure 1) (Shi, et al., 2020b).